Oxbryta was one of the centerpieces of Pfizer's $5.4 billion acquisition ... If Agios' experimental drug, mitapivat, shows a ...

Pfizer had shelved the drug after it appeared that AstraZeneca would beat it to market with a competing drug. But mirdametinib still held value to the NF1 community, so the Children’s Tumor ...

Pfizer. "Today’s approval further reinforces the important role of ADCETRIS as an existing standard of care with overall survival improvement shown for certain types of lymphomas, and now allows ...

AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections, including those caused by drug-resistant bacteria.

Pfizer has rights to the drug in the U.S. and Canada ... as a first-in-class treatment for moderate-to-severe acute pain in adults. The twice-daily pill targets NaV1.8, a pathway in the peripheral ...

(NEW YORK) — The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called ...

An experimental breast cancer treatment co-developed by Pfizer and Arvinas significantly improved the time some patients ...

For decades, women have trusted Depo-Provera, a birth control injection manufactured by Pfizer, as a convenient and effective ...

The pharmaceutical industry has been closely monitoring this case, as Dr Reddy's used a novel approach to make its generic drug. Pfizer's original patent on amlodipine besylate (US Patent ...